Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gadobutrol-enhanced MRA for supra-aortic arterial disease
CTR20132872Phase 3Completed
- Sponsor
- Bayer
- Start
- May 2014
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gadobutrol, sponsored by Bayer. Started May 2014; status: completed.
02
Drugs
gadobutrol
Beyond the preview
Go deeper on CTR20132872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132872.